Similar, but not biosimilar: Lilly and BI's Lantus copy approved in US
The US FDA has approved Basaglar, a ‘follow-on’ version of Sanofi’s long-acting insulin Lantus developed in a joint venture between Eli Lilly and Boehringer Ingelheim.
Archives for December 18, 2015
Sweden to back biomanufacturing through SEK320m investment scheme
The Swedish Government has announced a multi-million kronor plan to back biopharmaceutical research and manufacturing in the country.